ENTRY       hsa05168                    Pathway
NAME        Herpes simplex virus 1 infection - Homo sapiens (human)
DESCRIPTION Herpes simplex virus 1(HSV-1) is a common human pathogen, which initially infects orofacial mucosal surfaces. The virus replicates in epithelial cells at these sites, causing clinically overt disease characterized by vesicular lesions. HSV-1 then penetrates to the nervous system and establishes latency in sensory neurons. Throughout the lifetime of the host, HSV-1 may reactivate from its latent state and reinitiate a lytic infection cycle. HSV-1 has developed various mechanisms to escape its host innate immune responses and increased its capacity to replicate and to persist. ICP34.5, ICP0, ICP27, Us11 and Vhs (UL41) are the proteins involved in viral interference.
CLASS       Human Diseases; Infectious disease: viral
PATHWAY_MAP hsa05168  Herpes simplex virus 1 infection
NETWORK     nt06168  Herpes simplex virus 1 (HSV-1)
            nt06513  Complement cascade
            nt06516  TNF signaling
            nt06517  TLR signaling
            nt06519  RLR signaling
            nt06520  CGAS-STING signaling
            nt06521  NLR signaling
            nt06522  mTOR signaling
            nt06524  Apoptosis
  ELEMENT   N00560  HSV gD to HVEM-NFKB signaling pathway
            N00561  HSV ICP0 to TLR2/4-NFKB signaling pathway
            N00562  HSV US3 to TLR2/4-NFKB signaling pathway
            N00564  HSV US3 to TLR3-NFKB signaling pathway
            N00565  HSV US11 to RIG-I-like receptor signaling pathway
            N00566  HSV UL36USP to RIG-I-like receptor signaling pathway
            N00567  HSV ICP34.5 to TBK1 signaling pathway
            N00568  HSV US3 to IRF3 signaling pathway
            N00569  HSV UL41 to cGAS-STING signaling pathway
            N00570  HSV ICP0 to cGAS-STING signaling pathway
            N00572  HSV ICP34.5 to PKR-eIF2alpha signaling pathway
            N00573  HSV US11 to PKR-eIF2alpha signaling pathway
            N00574  HSV US11 to oligoadenylate synthetase (OAS)/RNase L pathway
            N00575  HSV ICP27 to IFN signaling pathway
            N00576  HSV UL41/UL13 to IFN signaling pathway
            N00577  HSV UL41 to IFN signaling pathway
            N00578  HSV UL41 to IFN signaling pathway
            N00579  HSV ICP6 to extrinsic apoptotic pathway
            N00580  HSV ICP0 to crosstalk between extrinsic and intrinsic apoptotic pathways
            N00581  HSV ICP47 to antigen processing and presentation by MHC class I molecules
            N00583  HSV VP11/12 to PI3K signaling pathway
            N00584  HSV US3 to MTOR signaling pathway
            N00585  HSV US3 to intrinsic apoptotic pathway
            N00587  HSV ICP27 to Nuclear export of mRNA
            N00588  HSV VP16 to Oct-1-mediated transcription
            N00589  HSV gC to alternative pathway of complement cascade
            N00591  HSV gB to antigen processing and presentation by MHC class II molecules
            N00592  HSV ICP0 to p53-mediated transcription
DISEASE     H00365  Herpes simplex virus infection; HSV infection
ORGANISM    Homo sapiens (human) [GN:hsa]
GENE        10000  AKT3; AKT serine/threonine kinase 3 [KO:K04456] [EC:2.7.11.1]
            10189  ALYREF; Aly/REF export factor [KO:K12881]
            10379  IRF9; interferon regulatory factor 9 [KO:K04693]
            10454  TAB1; TGF-beta activated kinase 1 (MAP3K7) binding protein 1 [KO:K04403]
            10482  NXF1; nuclear RNA export factor 1 [KO:K14284]
            10929  SRSF8; serine and arginine rich splicing factor 8 [KO:K12891]
            110117499  P3R3URF-PIK3R3; P3R3URF-PIK3R3 readthrough [KO:K02649]
            1147  CHUK; component of inhibitor of nuclear factor kappa B kinase complex [KO:K04467] [EC:2.7.11.10]
            115004  CGAS; cyclic GMP-AMP synthase [KO:K17834] [EC:2.7.7.86]
            148022  TICAM1; TIR domain containing adaptor molecule 1 [KO:K05842]
            1616  DAXX; death domain associated protein [KO:K02308]
            1965  EIF2S1; eukaryotic translation initiation factor 2 subunit alpha [KO:K03237]
            1967  EIF2B1; eukaryotic translation initiation factor 2B subunit alpha [KO:K03239]
            1978  EIF4EBP1; eukaryotic translation initiation factor 4E binding protein 1 [KO:K07205]
            207  AKT1; AKT serine/threonine kinase 1 [KO:K04456] [EC:2.7.11.1]
            208  AKT2; AKT serine/threonine kinase 2 [KO:K04456] [EC:2.7.11.1]
            23118  TAB2; TGF-beta activated kinase 1 (MAP3K7) binding protein 2 [KO:K04404]
            23586  RIGI; RNA sensor RIG-I [KO:K12646] [EC:5.6.2.6]
            2475  MTOR; mechanistic target of rapamycin kinase [KO:K07203] [EC:2.7.11.1]
            25833  POU2F3; POU class 2 homeobox 3 [KO:K09364]
            27102  EIF2AK1; eukaryotic translation initiation factor 2 alpha kinase 1 [KO:K16194] [EC:2.7.11.1]
            29110  TBK1; TANK binding kinase 1 [KO:K05410] [EC:2.7.11.10]
            2923  PDIA3; protein disulfide isomerase family A member 3 [KO:K08056] [EC:5.3.4.1]
            29915  HCFC2; host cell factor C2 [KO:K27390]
            29990  PILRB; paired immunoglobin like type 2 receptor beta [KO:K15411]
            29992  PILRA; paired immunoglobin like type 2 receptor alpha [KO:K15411]
            3054  HCFC1; host cell factor C1 [KO:K14966]
            3105  HLA-A; major histocompatibility complex, class I, A [KO:K06751]
            3106  HLA-B; major histocompatibility complex, class I, B [KO:K06751]
            3107  HLA-C; major histocompatibility complex, class I, C [KO:K06751]
            3108  HLA-DMA; major histocompatibility complex, class II, DM alpha [KO:K06752]
            3109  HLA-DMB; major histocompatibility complex, class II, DM beta [KO:K06752]
            3111  HLA-DOA; major histocompatibility complex, class II, DO alpha [KO:K06752]
            3112  HLA-DOB; major histocompatibility complex, class II, DO beta [KO:K06752]
            3113  HLA-DPA1; major histocompatibility complex, class II, DP alpha 1 [KO:K06752]
            3115  HLA-DPB1; major histocompatibility complex, class II, DP beta 1 [KO:K06752]
            3117  HLA-DQA1; major histocompatibility complex, class II, DQ alpha 1 [KO:K06752]
            3118  HLA-DQA2; major histocompatibility complex, class II, DQ alpha 2 [KO:K06752]
            3119  HLA-DQB1; major histocompatibility complex, class II, DQ beta 1 [KO:K06752]
            3120  HLA-DQB2; major histocompatibility complex, class II, DQ beta 2 [KO:K06752]
            3122  HLA-DRA; major histocompatibility complex, class II, DR alpha [KO:K06752]
            3123  HLA-DRB1; major histocompatibility complex, class II, DR beta 1 [KO:K06752]
            3125  HLA-DRB3; major histocompatibility complex, class II, DR beta 3 [KO:K06752]
            3126  HLA-DRB4; major histocompatibility complex, class II, DR beta 4 [KO:K06752]
            3127  HLA-DRB5; major histocompatibility complex, class II, DR beta 5 [KO:K06752]
            3133  HLA-E; major histocompatibility complex, class I, E [KO:K06751]
            3134  HLA-F; major histocompatibility complex, class I, F [KO:K06751]
            3135  HLA-G; major histocompatibility complex, class I, G [KO:K06751]
            317  APAF1; apoptotic peptidase activating factor 1 [KO:K02084]
            329  BIRC2; baculoviral IAP repeat containing 2 [KO:K16060]
            330  BIRC3; baculoviral IAP repeat containing 3 [KO:K16060]
            340061  STING1; stimulator of interferon response cGAMP interactor 1 [KO:K12654]
            3439  IFNA1; interferon alpha 1 [KO:K05414]
            3440  IFNA2; interferon alpha 2 [KO:K05414]
            3441  IFNA4; interferon alpha 4 [KO:K05414]
            3442  IFNA5; interferon alpha 5 [KO:K05414]
            3443  IFNA6; interferon alpha 6 [KO:K05414]
            3444  IFNA7; interferon alpha 7 [KO:K05414]
            3445  IFNA8; interferon alpha 8 [KO:K05414]
            3446  IFNA10; interferon alpha 10 [KO:K05414]
            3447  IFNA13; interferon alpha 13 [KO:K05414]
            3448  IFNA14; interferon alpha 14 [KO:K05414]
            3449  IFNA16; interferon alpha 16 [KO:K05414]
            3451  IFNA17; interferon alpha 17 [KO:K05414]
            3452  IFNA21; interferon alpha 21 [KO:K05414]
            3454  IFNAR1; interferon alpha and beta receptor subunit 1 [KO:K05130]
            3455  IFNAR2; interferon alpha and beta receptor subunit 2 [KO:K05131]
            3456  IFNB1; interferon beta 1 [KO:K05415]
            3458  IFNG; interferon gamma [KO:K04687]
            3459  IFNGR1; interferon gamma receptor 1 [KO:K05132]
            3460  IFNGR2; interferon gamma receptor 2 [KO:K05133]
            355  FAS; Fas cell surface death receptor [KO:K04390]
            3551  IKBKB; inhibitor of nuclear factor kappa B kinase subunit beta [KO:K07209] [EC:2.7.11.10]
            3553  IL1B; interleukin 1 beta [KO:K04519]
            356  FASLG; Fas ligand [KO:K04389]
            3569  IL6; interleukin 6 [KO:K05405]
            3592  IL12A; interleukin 12A [KO:K05406]
            3593  IL12B; interleukin 12B [KO:K05425]
            3654  IRAK1; interleukin 1 receptor associated kinase 1 [KO:K04730] [EC:2.7.11.1]
            3661  IRF3; interferon regulatory factor 3 [KO:K05411]
            3665  IRF7; interferon regulatory factor 7 [KO:K09447]
            3678  ITGA5; integrin subunit alpha 5 [KO:K06484]
            3690  ITGB3; integrin subunit beta 3 [KO:K06493]
            3716  JAK1; Janus kinase 1 [KO:K11217] [EC:2.7.10.2]
            3717  JAK2; Janus kinase 2 [KO:K04447] [EC:2.7.10.2]
            4049  LTA; lymphotoxin alpha [KO:K05468]
            440275  EIF2AK4; eukaryotic translation initiation factor 2 alpha kinase 4 [KO:K16196] [EC:2.7.11.1]
            4615  MYD88; MYD88 innate immune signal transduction adaptor [KO:K04729]
            4790  NFKB1; nuclear factor kappa B subunit 1 [KO:K02580]
            4792  NFKBIA; NFKB inhibitor alpha [KO:K04734]
            4938  OAS1; 2'-5'-oligoadenylate synthetase 1 [KO:K14216] [EC:2.7.7.84]
            4939  OAS2; 2'-5'-oligoadenylate synthetase 2 [KO:K14216] [EC:2.7.7.84]
            4940  OAS3; 2'-5'-oligoadenylate synthetase 3 [KO:K14216] [EC:2.7.7.84]
            51135  IRAK4; interleukin 1 receptor associated kinase 4 [KO:K04733] [EC:2.7.11.1]
            5199  CFP; complement factor properdin [KO:K15412]
            5290  PIK3CA; phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha [KO:K00922] [EC:2.7.1.153]
            5291  PIK3CB; phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta [KO:K00922] [EC:2.7.1.153]
            5293  PIK3CD; phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta [KO:K00922] [EC:2.7.1.153]
            5295  PIK3R1; phosphoinositide-3-kinase regulatory subunit 1 [KO:K02649]
            5296  PIK3R2; phosphoinositide-3-kinase regulatory subunit 2 [KO:K02649]
            5371  PML; PML nuclear body scaffold [KO:K10054] [EC:2.3.2.-]
            54106  TLR9; toll like receptor 9 [KO:K10161]
            54205  CYCS; cytochrome c, somatic [KO:K08738]
            5451  POU2F1; POU class 2 homeobox 1 [KO:K09364]
            5452  POU2F2; POU class 2 homeobox 2 [KO:K09364]
            5499  PPP1CA; protein phosphatase 1 catalytic subunit alpha [KO:K06269] [EC:3.1.3.16]
            5500  PPP1CB; protein phosphatase 1 catalytic subunit beta [KO:K06269] [EC:3.1.3.16]
            5501  PPP1CC; protein phosphatase 1 catalytic subunit gamma [KO:K06269] [EC:3.1.3.16]
            56000  NXF3; nuclear RNA export factor 3 [KO:K14284]
            56001  NXF2; nuclear RNA export factor 2 [KO:K14284]
            5610  EIF2AK2; eukaryotic translation initiation factor 2 alpha kinase 2 [KO:K16195] [EC:2.7.11.1]
            567  B2M; beta-2-microglobulin [KO:K08055]
            56829  ZC3HAV1; zinc finger CCCH-type containing, antiviral 1 [KO:K28004]
            572  BAD; BCL2 associated agonist of cell death [KO:K02158]
            57506  MAVS; mitochondrial antiviral signaling protein [KO:K12648]
            578  BAK1; BCL2 antagonist/killer 1 [KO:K14021]
            5781  PTPN11; protein tyrosine phosphatase non-receptor type 11 [KO:K07293] [EC:3.1.3.48]
            581  BAX; BCL2 associated X, apoptosis regulator [KO:K02159]
            5818  NECTIN1; nectin cell adhesion molecule 1 [KO:K06081]
            5819  NECTIN2; nectin cell adhesion molecule 2 [KO:K06531]
            596  BCL2; BCL2 apoptosis regulator [KO:K02161]
            5970  RELA; RELA proto-oncogene, NF-kB subunit [KO:K04735]
            598  BCL2L1; BCL2 like 1 [KO:K04570]
            6009  RHEB; Ras homolog, mTORC1 binding [KO:K07208]
            6041  RNASEL; ribonuclease L [KO:K01165]
            6347  CCL2; C-C motif chemokine ligand 2 [KO:K14624]
            6352  CCL5; C-C motif chemokine ligand 5 [KO:K12499]
            637  BID; BH3 interacting domain death agonist [KO:K04726]
            64135  IFIH1; interferon induced with helicase C domain 1 [KO:K12647] [EC:5.6.2.6]
            64170  CARD9; caspase recruitment domain family member 9 [KO:K12794]
            6426  SRSF1; serine and arginine rich splicing factor 1 [KO:K12890]
            6427  SRSF2; serine and arginine rich splicing factor 2 [KO:K12891]
            6428  SRSF3; serine and arginine rich splicing factor 3 [KO:K12892]
            6429  SRSF4; serine and arginine rich splicing factor 4 [KO:K12893]
            6430  SRSF5; serine and arginine rich splicing factor 5 [KO:K12893]
            6431  SRSF6; serine and arginine rich splicing factor 6 [KO:K12893]
            6432  SRSF7; serine and arginine rich splicing factor 7 [KO:K12896]
            6672  SP100; SP100 nuclear antigen [KO:K15413]
            6714  SRC; SRC proto-oncogene, non-receptor tyrosine kinase [KO:K05704] [EC:2.7.10.2]
            6732  SRPK1; SRSF protein kinase 1 [KO:K15409] [EC:2.7.11.1]
            6772  STAT1; signal transducer and activator of transcription 1 [KO:K11220]
            6773  STAT2; signal transducer and activator of transcription 2 [KO:K11221]
            684  BST2; bone marrow stromal cell antigen 2 [KO:K06731]
            6850  SYK; spleen associated tyrosine kinase [KO:K05855] [EC:2.7.10.2]
            6885  MAP3K7; mitogen-activated protein kinase kinase kinase 7 [KO:K04427] [EC:2.7.11.25]
            6890  TAP1; transporter 1, ATP binding cassette subfamily B member [KO:K05653] [EC:7.4.2.14]
            6891  TAP2; transporter 2, ATP binding cassette subfamily B member [KO:K05654] [EC:7.4.2.14]
            6892  TAPBP; TAP binding protein [KO:K08058]
            7097  TLR2; toll like receptor 2 [KO:K10159]
            7098  TLR3; toll like receptor 3 [KO:K05401]
            7124  TNF; tumor necrosis factor [KO:K03156]
            7132  TNFRSF1A; TNF receptor superfamily member 1A [KO:K03158]
            7157  TP53; tumor protein p53 [KO:K04451]
            718  C3; complement C3 [KO:K03990]
            7186  TRAF2; TNF receptor associated factor 2 [KO:K03173] [EC:2.3.2.27]
            7187  TRAF3; TNF receptor associated factor 3 [KO:K03174]
            7188  TRAF5; TNF receptor associated factor 5 [KO:K09849]
            7189  TRAF6; TNF receptor associated factor 6 [KO:K03175] [EC:2.3.2.27]
            7248  TSC1; TSC complex subunit 1 [KO:K07206]
            7249  TSC2; TSC complex subunit 2 [KO:K07207]
            727  C5; complement C5 [KO:K03994]
            728343  NXF2B; nuclear RNA export factor 2B [KO:K14284]
            7297  TYK2; tyrosine kinase 2 [KO:K11219] [EC:2.7.10.2]
            811  CALR; calreticulin [KO:K08057]
            836  CASP3; caspase 3 [KO:K02187] [EC:3.4.22.56]
            841  CASP8; caspase 8 [KO:K04398] [EC:3.4.22.61]
            842  CASP9; caspase 9 [KO:K04399] [EC:3.4.22.62]
            8503  PIK3R3; phosphoinositide-3-kinase regulatory subunit 3 [KO:K02649]
            8517  IKBKG; inhibitor of nuclear factor kappa B kinase regulatory subunit gamma [KO:K07210]
            8683  SRSF9; serine and arginine rich splicing factor 9 [KO:K21123]
            8717  TRADD; TNFRSF1A associated via death domain [KO:K03171]
            8740  TNFSF14; TNF superfamily member 14 [KO:K05477]
            8764  TNFRSF14; TNF receptor superfamily member 14 [KO:K05152]
            8772  FADD; Fas associated via death domain [KO:K02373]
            8890  EIF2B4; eukaryotic translation initiation factor 2B subunit delta [KO:K03680]
            8891  EIF2B3; eukaryotic translation initiation factor 2B subunit gamma [KO:K03241]
            8892  EIF2B2; eukaryotic translation initiation factor 2B subunit beta [KO:K03754]
            8893  EIF2B5; eukaryotic translation initiation factor 2B subunit epsilon [KO:K03240]
            9021  SOCS3; suppressor of cytokine signaling 3 [KO:K04696]
            9451  EIF2AK3; eukaryotic translation initiation factor 2 alpha kinase 3 [KO:K08860] [EC:2.7.11.1]
            9641  IKBKE; inhibitor of nuclear factor kappa B kinase subunit epsilon [KO:K07211] [EC:2.7.11.10]
            972  CD74; CD74 molecule [KO:K06505]
COMPOUND    C05981  Phosphatidylinositol-3,4,5-trisphosphate
            C20640  Cyclic GMP-AMP
            C20935  2-5A
REFERENCE   PMID:12787566
  AUTHORS   Granger SW, Rickert S
  TITLE     LIGHT-HVEM signaling and the regulation of T cell-mediated immunity.
  JOURNAL   Cytokine Growth Factor Rev 14:289-96 (2003)
            DOI:10.1016/S1359-6101(03)00031-5
REFERENCE   PMID:19495760
  AUTHORS   Steinberg MW, Shui JW, Ware CF, Kronenberg M
  TITLE     Regulating the mucosal immune system: the contrasting roles of LIGHT, HVEM, and their various partners.
  JOURNAL   Semin Immunopathol 31:207-21 (2009)
            DOI:10.1007/s00281-009-0157-4
REFERENCE   PMID:20221426
  AUTHORS   MacLeod IJ, Minson T
  TITLE     Binding of herpes simplex virus type-1 virions leads to the induction of intracellular signalling in the absence of virus entry.
  JOURNAL   PLoS One 5:e9560 (2010)
            DOI:10.1371/journal.pone.0009560
REFERENCE   PMID:23150579
  AUTHORS   Gianni T, Leoni V, Chesnokova LS, Hutt-Fletcher LM, Campadelli-Fiume G
  TITLE     alphavbeta3-integrin is a major sensor and activator of innate immunity to herpes simplex virus-1.
  JOURNAL   Proc Natl Acad Sci U S A 109:19792-7 (2012)
            DOI:10.1073/pnas.1212597109
REFERENCE   PMID:25375272
  AUTHORS   Gianni T, Campadelli-Fiume G
  TITLE     The epithelial alphavbeta3-integrin boosts the MYD88-dependent TLR2 signaling in response to viral and bacterial components.
  JOURNAL   PLoS Pathog 10:e1004477 (2014)
            DOI:10.1371/journal.ppat.1004477
REFERENCE   PMID:15056211
  AUTHORS   Spear PG
  TITLE     Herpes simplex virus: receptors and ligands for cell entry.
  JOURNAL   Cell Microbiol 6:401-10 (2004)
            DOI:10.1111/j.1462-5822.2004.00389.x
REFERENCE   PMID:12855695
  AUTHORS   Boutell C, Everett RD
  TITLE     The herpes simplex virus type 1 (HSV-1) regulatory protein ICP0 interacts with and Ubiquitinates p53.
  JOURNAL   J Biol Chem 278:36596-602 (2003)
            DOI:10.1074/jbc.M300776200
REFERENCE   PMID:24262390
  AUTHORS   Ma Y, He B
  TITLE     Recognition of herpes simplex viruses: toll-like receptors and beyond.
  JOURNAL   J Mol Biol 426:1133-47 (2014)
            DOI:10.1016/j.jmb.2013.11.012
REFERENCE   PMID:26952111
  AUTHORS   Su C, Zhan G, Zheng C
  TITLE     Evasion of host antiviral innate immunity by HSV-1, an update.
  JOURNAL   Virol J 13:38 (2016)
            DOI:10.1186/s12985-016-0495-5
REFERENCE   PMID:21994567
  AUTHORS   Melchjorsen J, Matikainen S, Paludan SR
  TITLE     Activation and evasion of innate antiviral immunity by herpes simplex virus.
  JOURNAL   Viruses 1:737-59 (2009)
            DOI:10.3390/v1030737
REFERENCE   PMID:15276609
  AUTHORS   Morrison LA
  TITLE     The Toll of herpes simplex virus infection.
  JOURNAL   Trends Microbiol 12:353-6 (2004)
            DOI:10.1016/j.tim.2004.06.001
REFERENCE   PMID:29298887
  AUTHORS   Zheng C
  TITLE     Evasion of Cytosolic DNA-Stimulated Innate Immune Responses by Herpes Simplex Virus 1.
  JOURNAL   J Virol 92:e00099-17 (2018)
            DOI:10.1128/JVI.00099-17
REFERENCE   PMID:19344302
  AUTHORS   Grandi P, Peruzzi P, Reinhart B, Cohen JB, Chiocca EA, Glorioso JC
  TITLE     Design and application of oncolytic HSV vectors for glioblastoma therapy.
  JOURNAL   Expert Rev Neurother 9:505-17 (2009)
            DOI:10.1586/ern.09.9
REFERENCE   PMID:23115300
  AUTHORS   Lussignol M, Queval C, Bernet-Camard MF, Cotte-Laffitte J, Beau I, Codogno P, Esclatine A
  TITLE     The herpes simplex virus 1 Us11 protein inhibits autophagy through its interaction with the protein kinase PKR.
  JOURNAL   J Virol 87:859-71 (2013)
            DOI:10.1128/JVI.01158-12
REFERENCE   PMID:17229694
  AUTHORS   Sanchez R, Mohr I
  TITLE     Inhibition of cellular 2'-5' oligoadenylate synthetase by the herpes simplex virus type 1 Us11 protein.
  JOURNAL   J Virol 81:3455-64 (2007)
            DOI:10.1128/JVI.02520-06
REFERENCE   PMID:12826401
  AUTHORS   Wysocka J, Herr W
  TITLE     The herpes simplex virus VP16-induced complex: the makings of a regulatory switch.
  JOURNAL   Trends Biochem Sci 28:294-304 (2003)
            DOI:10.1016/S0968-0004(03)00088-4
REFERENCE   PMID:27367734
  AUTHORS   Fleming SB
  TITLE     Viral Inhibition of the IFN-Induced JAK/STAT Signalling Pathway: Development of Live Attenuated Vaccines by Mutation of Viral-Encoded IFN-Antagonists.
  JOURNAL   Vaccines (Basel) 4:E23 (2016)
            DOI:10.3390/vaccines4030023
REFERENCE   PMID:15163721
  AUTHORS   Yokota S, Yokosawa N, Okabayashi T, Suzutani T, Miura S, Jimbow K, Fujii N
  TITLE     Induction of suppressor of cytokine signaling-3 by herpes simplex virus type 1 contributes to inhibition of the interferon signaling pathway.
  JOURNAL   J Virol 78:6282-6 (2004)
            DOI:10.1128/JVI.78.12.6282-6286.2004
REFERENCE   PMID:23864622
  AUTHORS   Gu H, Zheng Y, Roizman B
  TITLE     Interaction of herpes simplex virus ICP0 with ND10 bodies: a sequential process of adhesion, fusion, and retention.
  JOURNAL   J Virol 87:10244-54 (2013)
            DOI:10.1128/JVI.01487-13
REFERENCE   PMID:21994592
  AUTHORS   Tavalai N, Stamminger T
  TITLE     Interplay between Herpesvirus Infection and Host Defense by PML Nuclear Bodies.
  JOURNAL   Viruses 1:1240-64 (2009)
            DOI:10.3390/v1031240
REFERENCE   PMID:21146386
  AUTHORS   Horst D, Verweij MC, Davison AJ, Ressing ME, Wiertz EJ
  TITLE     Viral evasion of T cell immunity: ancient mechanisms offering new applications.
  JOURNAL   Curr Opin Immunol 23:96-103 (2011)
            DOI:10.1016/j.coi.2010.11.005
REFERENCE   PMID:12960333
  AUTHORS   Neumann J, Eis-Hubinger AM, Koch N
  TITLE     Herpes simplex virus type 1 targets the MHC class II processing pathway for immune evasion.
  JOURNAL   J Immunol 171:3075-83 (2003)
            DOI:10.4049/jimmunol.171.6.3075
REFERENCE   PMID:25798530
  AUTHORS   Liu X, Cohen JI
  TITLE     The role of PI3K/Akt in human herpesvirus infection: From the bench to the bedside.
  JOURNAL   Virology 479-480:568-77 (2015)
            DOI:10.1016/j.virol.2015.02.040
REFERENCE   PMID:28468873
  AUTHORS   Vink EI, Smiley JR, Mohr I
  TITLE     Subversion of Host Responses to Energy Insufficiency by Us3 Supports Herpes Simplex Virus 1 Replication during Stress.
  JOURNAL   J Virol 91:e00295-17 (2017)
            DOI:10.1128/JVI.00295-17
REFERENCE   PMID:18508584
  AUTHORS   Sandri-Goldin RM
  TITLE     The many roles of the regulatory protein ICP27 during herpes simplex virus infection.
  JOURNAL   Front Biosci 13:5241-56 (2008)
            DOI:10.2741/3078
REFERENCE   PMID:15078920
  AUTHORS   Sandri-Goldin RM
  TITLE     Viral regulation of mRNA export.
  JOURNAL   J Virol 78:4389-96 (2004)
            DOI:10.1128/JVI.78.9.4389-4396.2004
REFERENCE   PMID:27154074
  AUTHORS   Yu X, He S
  TITLE     The interplay between human herpes simplex virus infection and the apoptosis and necroptosis cell death pathways.
  JOURNAL   Virol J 13:77 (2016)
            DOI:10.1186/s12985-016-0528-0
REL_PATHWAY hsa03040  Spliceosome
            hsa03050  Proteasome
            hsa04115  p53 signaling pathway
            hsa04151  PI3K-Akt signaling pathway
            hsa04210  Apoptosis
            hsa04610  Complement and coagulation cascades
            hsa04612  Antigen processing and presentation
            hsa04620  Toll-like receptor signaling pathway
            hsa04622  RIG-I-like receptor signaling pathway
            hsa04630  JAK-STAT signaling pathway
KO_PATHWAY  ko05168
///
